Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release

Míreanna comhchosúla

• Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release
  de réir: Karlowsky, James A., et al.
  Foilsithe / Cruthaithe: (2002)
• Longitudinal Assessment of Antipneumococcal Susceptibility in the United States
  de réir: Jones, Mark E., et al.
  Foilsithe / Cruthaithe: (2002)
• Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States
  de réir: Karlowsky, James A., et al.
  Foilsithe / Cruthaithe: (2003)
• In Vitro Activities of Novel Nonfluorinated Quinolones PGE 9262932 and PGE 9509924 against Clinical Isolates of Staphylococcus aureus and Streptococcus pneumoniae with Defined Mutations in DNA Gyrase and Topoisomerase IV
  de réir: Jones, Mark E., et al.
  Foilsithe / Cruthaithe: (2002)
• In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
  de réir: Wenzel, Richard P., et al.
  Foilsithe / Cruthaithe: (2003)